STOCK TITAN

[Form 4] Cardinal Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Cardinal Health insider transaction summary: Mary C. Scherer, listed as Chief Accounting Officer and reporting person for Cardinal Health, reported an acquisition of 3,029 common shares recorded as performance share units tied to the issuer. The transaction date is listed as 08/12/2025 and the filing states these performance share units will settle on August 15, 2025. Following the reported transaction the filing shows 11,691 common shares beneficially owned by the reporting person. The entry lists a $0 price, consistent with compensation-settled awards. This filing records a routine equity award rather than an open-market purchase or sale.

Riepilogo della transazione di insider di Cardinal Health: Mary C. Scherer, indicata come Chief Accounting Officer e soggetto dichiarante per Cardinal Health, ha segnalato l'acquisizione di 3,029 azioni ordinarie registrate come unità azionarie legate alla performance dell'emittente. La data dell'operazione è indicata come 08/12/2025 e il documento dichiara che queste unità si estingueranno il 15 agosto 2025. A seguito dell'operazione, la segnalazione mostra la detenzione beneficiaria di 11,691 azioni ordinarie da parte del dichiarante. L'annotazione riporta un prezzo di $0, coerente con premi liquidati come compenso. Questa comunicazione registra una normale assegnazione di azioni e non un acquisto o una vendita sul mercato aperto.

Resumen de la transacción de un insider de Cardinal Health: Mary C. Scherer, indicada como Chief Accounting Officer y persona declarante para Cardinal Health, informó la adquisición de 3,029 acciones ordinarias registradas como unidades de acciones por desempeño vinculadas al emisor. La fecha de la operación figura como 08/12/2025 y la presentación indica que estas unidades se liquidarán el 15 de agosto de 2025. Tras la operación, el registro muestra que la persona declarante posee beneficiariamente 11,691 acciones ordinarias. La anotación registra un precio de $0, coherente con compensaciones liquidadas como retribución. Este informe documenta una adjudicación de acciones de rutina y no una compra o venta en el mercado abierto.

Cardinal Health 내부자 거래 요약: Mary C. Scherer는 Chief Accounting Officer로 기재되어 있으며 Cardinal Health의 신고인으로서 발행사 성과 기준의 단위로 기록된 3,029 보통주를 취득했다고 보고했습니다. 거래일은 08/12/2025로 기재되어 있고 제출 서류에는 이 단위들이 2025년 8월 15일에 정산될 예정입니다라고 명시되어 있습니다. 보고된 거래 이후 제출서류에는 신고인이 실질적으로 보유한 11,691 보통주가 표시되어 있습니다. 해당 항목의 가격은 $0로 기재되어 있으며, 이는 보상으로 정산되는 부여와 일치합니다. 이 제출은 공개시장 매수나 매도가 아닌 통상적인 주식 부여를 기록한 것입니다.

Résumé de la transaction d'initié de Cardinal Health : Mary C. Scherer, figurant en tant que Chief Accounting Officer et personne déclarante pour Cardinal Health, a déclaré l'acquisition de 3,029 actions ordinaires comptabilisées comme des unités d'actions liées à la performance de l'émetteur. La date de la transaction est indiquée comme 08/12/2025 et le dépôt précise que ces unités seront réglées le 15 août 2025. Suite à la transaction déclarée, le dépôt fait état de 11,691 actions ordinaires détenues à titre bénéficiaire par la personne déclarante. L'entrée indique un prix de $0, conforme à des attributions réglées en tant que rémunération. Ce dépôt enregistre une attribution d'actions de routine plutôt qu'un achat ou une vente sur le marché ouvert.

Zusammenfassung der Insider-Transaktion von Cardinal Health: Mary C. Scherer, aufgeführt als Chief Accounting Officer und meldepflichtige Person für Cardinal Health, meldete den Erwerb von 3,029 Stammaktien, die als performance share units an den Emittenten gebunden verbucht wurden. Das Transaktionsdatum ist mit 08/12/2025 angegeben und die Einreichung erklärt, dass diese Einheiten am 15. August 2025 abgewickelt werden. Nach der gemeldeten Transaktion weist die Einreichung 11,691 Stammaktien aus, die der meldenden Person wirtschaftlich zustehen. Der Eintrag nennt einen Preis von $0, was mit als Vergütung abgewickelten Zuwendungen übereinstimmt. Diese Meldung dokumentiert eine routinemäßige Aktienzuteilung und keinen Kauf oder Verkauf am offenen Markt.

Positive
  • Acquisition recorded: Reporting person acquired 3,029 common shares via performance share units.
  • Beneficial ownership disclosed: Filing reports 11,691 common shares beneficially owned following the transaction.
Negative
  • None.

Insights

TL;DR: Routine officer equity award documented; no new red flags for governance or disclosure practices.

The Form 4 shows Mary C. Scherer, Chief Accounting Officer, receiving 3,029 common shares via performance share units that are scheduled to settle on August 15, 2025. The filing discloses beneficial ownership of 11,691 shares after the transaction and lists a price of $0, consistent with compensation-based settlement. From a governance standpoint, the filing is complete on its face and aligns with typical executive equity compensation disclosures; it does not indicate accelerated vesting, related-party transactions, or other atypical arrangements in this text.

TL;DR: Compensation award recorded as performance share units; transaction appears routine and non-cash.

The reported transaction is classified as an acquisition of performance share units totaling 3,029 shares, with settlement noted on August 15, 2025. The Form 4 shows these units at $0 price, which is standard for equity awards granted as part of compensation programs. The filing indicates the reporting person will beneficially own 11,691 shares after settlement. There are no derivative or open-market transactions disclosed in Table II of this filing.

Riepilogo della transazione di insider di Cardinal Health: Mary C. Scherer, indicata come Chief Accounting Officer e soggetto dichiarante per Cardinal Health, ha segnalato l'acquisizione di 3,029 azioni ordinarie registrate come unità azionarie legate alla performance dell'emittente. La data dell'operazione è indicata come 08/12/2025 e il documento dichiara che queste unità si estingueranno il 15 agosto 2025. A seguito dell'operazione, la segnalazione mostra la detenzione beneficiaria di 11,691 azioni ordinarie da parte del dichiarante. L'annotazione riporta un prezzo di $0, coerente con premi liquidati come compenso. Questa comunicazione registra una normale assegnazione di azioni e non un acquisto o una vendita sul mercato aperto.

Resumen de la transacción de un insider de Cardinal Health: Mary C. Scherer, indicada como Chief Accounting Officer y persona declarante para Cardinal Health, informó la adquisición de 3,029 acciones ordinarias registradas como unidades de acciones por desempeño vinculadas al emisor. La fecha de la operación figura como 08/12/2025 y la presentación indica que estas unidades se liquidarán el 15 de agosto de 2025. Tras la operación, el registro muestra que la persona declarante posee beneficiariamente 11,691 acciones ordinarias. La anotación registra un precio de $0, coherente con compensaciones liquidadas como retribución. Este informe documenta una adjudicación de acciones de rutina y no una compra o venta en el mercado abierto.

Cardinal Health 내부자 거래 요약: Mary C. Scherer는 Chief Accounting Officer로 기재되어 있으며 Cardinal Health의 신고인으로서 발행사 성과 기준의 단위로 기록된 3,029 보통주를 취득했다고 보고했습니다. 거래일은 08/12/2025로 기재되어 있고 제출 서류에는 이 단위들이 2025년 8월 15일에 정산될 예정입니다라고 명시되어 있습니다. 보고된 거래 이후 제출서류에는 신고인이 실질적으로 보유한 11,691 보통주가 표시되어 있습니다. 해당 항목의 가격은 $0로 기재되어 있으며, 이는 보상으로 정산되는 부여와 일치합니다. 이 제출은 공개시장 매수나 매도가 아닌 통상적인 주식 부여를 기록한 것입니다.

Résumé de la transaction d'initié de Cardinal Health : Mary C. Scherer, figurant en tant que Chief Accounting Officer et personne déclarante pour Cardinal Health, a déclaré l'acquisition de 3,029 actions ordinaires comptabilisées comme des unités d'actions liées à la performance de l'émetteur. La date de la transaction est indiquée comme 08/12/2025 et le dépôt précise que ces unités seront réglées le 15 août 2025. Suite à la transaction déclarée, le dépôt fait état de 11,691 actions ordinaires détenues à titre bénéficiaire par la personne déclarante. L'entrée indique un prix de $0, conforme à des attributions réglées en tant que rémunération. Ce dépôt enregistre une attribution d'actions de routine plutôt qu'un achat ou une vente sur le marché ouvert.

Zusammenfassung der Insider-Transaktion von Cardinal Health: Mary C. Scherer, aufgeführt als Chief Accounting Officer und meldepflichtige Person für Cardinal Health, meldete den Erwerb von 3,029 Stammaktien, die als performance share units an den Emittenten gebunden verbucht wurden. Das Transaktionsdatum ist mit 08/12/2025 angegeben und die Einreichung erklärt, dass diese Einheiten am 15. August 2025 abgewickelt werden. Nach der gemeldeten Transaktion weist die Einreichung 11,691 Stammaktien aus, die der meldenden Person wirtschaftlich zustehen. Der Eintrag nennt einen Preis von $0, was mit als Vergütung abgewickelten Zuwendungen übereinstimmt. Diese Meldung dokumentiert eine routinemäßige Aktienzuteilung und keinen Kauf oder Verkauf am offenen Markt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Scherer Mary C.

(Last) (First) (Middle)
7000 CARDINAL PLACE

(Street)
DUBLIN OH 43017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/12/2025 A(1) 3,029 A $0 11,691 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects performance share units that will settle on August 15, 2025.
Remarks:
/s/ James E. Barnett, Attorney-in-fact 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Cardinal Health (CAH) Form 4 report?

The Form 4 reports an acquisition of 3,029 common shares recorded as performance share units on 08/12/2025.

Who is the reporting person on the CAH Form 4 and what is their role?

The reporting person is Mary C. Scherer, identified as the Chief Accounting Officer of Cardinal Health.

When will the reported performance share units settle?

The filing states the performance share units will settle on August 15, 2025.

How many Cardinal Health shares does the reporting person own after this transaction?

The Form 4 shows 11,691 common shares beneficially owned following the reported transaction.

Was any cash consideration reported for the acquisition?

No cash was reported; the filing lists a price of $0, consistent with compensation-settled awards.
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Latest News

CAH Latest SEC Filings

CAH Stock Data

37.63B
237.95M
0.29%
89.15%
2.39%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN